HistoIndex
PrivateLast Round
Series A
Extension
May 2, 2025
Total Funding Raised
$8.51M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
HistoIndex operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A Extension round in May 2025.
HistoIndex is a medical technology company that provides an AI-powered digital pathology platform using stain-free imaging for the visualization and quantification of fibrosis in biological tissues.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HistoIndex Comparables
Compare HistoIndex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmaNest Inc. | 82% | |
| Visiopharm | 75% | |
| Aignostics | 75% |
For institutional investors. Book with your work email.
HistoIndex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 2, 2025 | ||||
| Grant | Dec 14, 2020 | ||||
| Series A | Mar 11, 2016 | ||||
| VC Round | Jun 11, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HistoIndex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Series A Extension |
| OCBC Bank | Series A Extension |
| ZIG Ventures | Series A, VC Round, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 44% MoM.
- Jun 22, 2026
Monthly visitors grew 69% MoM, reaching 2.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 19, 2026
Histoindex Pte Ltd. showcases its digital pathology and AI-based tissue analysis capabilities at AASLD The Liver Meeting(R) Exhibition in Colorado in 2026.
- partners_withOct 19, 2026
Histoindex Pte Ltd. and A*STAR International sign a memorandum of understanding in Singapore on Oct 18th '26 to collaborate on the preclinical evaluation and characterization of therapeutic candidates for various fibrotic diseases, including cancer-associated fibrosis.
For institutional investors. Book with your work email.
HistoIndex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HistoIndex's valuation, stock price, and market status.
Is HistoIndex a public or private company?
HistoIndex is a private company.
What is the current stock price of HistoIndex?
HistoIndex is a private company, so its shares have no public market price. Caplight tracks HistoIndex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HistoIndex worth (valuation)?
Valuation information for HistoIndex is not publicly available.
Can I buy HistoIndex stock?
HistoIndex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HistoIndex's last funding round?
HistoIndex's most recent funding round was Series A Extension on May 2, 2025.
Who are the main investors in HistoIndex?
Key investors in HistoIndex include OCBC Bank.
Will HistoIndex IPO soon?
No public IPO plans have been announced for HistoIndex.
How can I track HistoIndex secondary market activity?
Caplight tracks bids, offers, and trades in HistoIndex's shares on secondary markets.